Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Net Cash Inflow / Outflow

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

AUROBINDO PHARMA Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹2,169 Cr₹-1,021 Cr₹223 Cr₹-1,164 Cr₹2,563 Cr

What is the latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA ?

The latest Net Cash Inflow / Outflow ratio of AUROBINDO PHARMA is ₹2,169 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹2,169 Cr
Mar2024₹-1,021 Cr
Mar2023₹223 Cr
Mar2022₹-1,164 Cr
Mar2021₹2,563 Cr

How is Net Cash Inflow / Outflow of AUROBINDO PHARMA Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹2,169 Cr
Positive
Mar2024 ₹-1,021 Cr
Negative
Mar2023 ₹223 Cr
Positive
Mar2022 ₹-1,164 Cr
Negative
Mar2021 ₹2,563 Cr -

Compare Net Cash Inflow / Outflow of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹77,949.2 Cr 4.8% 9.8% 9.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,713.0 Cr -1.4% -3.2% -0.5% Stock Analytics
DIVIS LABORATORIES ₹156,811.0 Cr -1.9% -8.7% 1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,052.0 Cr -3.5% -6.6% 30.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,927.0 Cr -4% -8.3% 6.3% Stock Analytics
CIPLA ₹96,602.7 Cr -1.9% -11.9% -19% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

4.8%

9.8%

9.1%

SENSEX

0.6%

-11.1%

-6.2%


You may also like the below Video Courses